Browsing by Subject "Neurodegenerative Diseases / drug therapy"
Now showing 1 - 2 of 2
- Results Per Page
- Sort Options
Item Current Strategies for Brain Drug Delivery(Ivyspring International Publisher, 2018-02-05) Dong, XiaoweiThe blood-brain barrier (BBB) has been a great hurdle for brain drug delivery. The BBB in healthy brain is a diffusion barrier essential for protecting normal brain function by impeding most compounds from transiting from the blood to the brain; only small molecules can cross the BBB. Under certain pathological conditions of diseases such as stroke, diabetes, seizures, multiple sclerosis, Parkinson's disease and Alzheimer disease, the BBB is disrupted. The objective of this review is to provide a broad overview on current strategies for brain drug delivery and related subjects from the past five years. It is hoped that this review could inspire readers to discover possible approaches to deliver drugs into the brain. After an initial overview of the BBB structure and function in both healthy and pathological conditions, this review re-visits, according to recent publications, some questions that are controversial, such as whether nanoparticles by themselves could cross the BBB and whether drugs are specifically transferred to the brain by actively targeted nanoparticles. Current non-nanoparticle strategies are also reviewed, such as delivery of drugs through the permeable BBB under pathological conditions and using non-invasive techniques to enhance brain drug uptake. Finally, one particular area that is often neglected in brain drug delivery is the influence of aging on the BBB, which is captured in this review based on the limited studies in the literature.Item Investigating the Effect of 17β-Estradiol on 24(S)-hydroxycholesterol Concentration in Brain Tissue(2021-05) Oaxaca, K. Celeste; Prokai, Laszlo; Prokai-Tatrai, Katalin; Lacko, Andras G.; Woerner, August E.Estrogen, more specifically 17β-estradiol (E2), has been found to have neuroprotective effects in the brain. With Alzheimer's patients being comprised mainly of women, it is worthwhile to investigate the role that reproductive senescence plays in the development and progression of the disease due to decreased levels of estrogen. The purpose of this research was to develop a method for analyzing how estrogen affects the concentration of 24(S)-hydroxycholesterol (24S-OHC) in brain tissue. Ovariectomized (OVX) CD1 mice we subjected to daily injections of E2 for 5 days. Cholesterol and 24SOHC from hippocampal tissue were analyzed by gas chromatography-mass spectrometry (GC-MS) assay developed for the purpose, and their concentrations were compared between the OVX E2 treated and OVX control groups. No significant difference was found between the two groups; nevertheless, the assay developed during this study will be beneficial for further investigation of E2 as a potential modulator of cholesterol metabolism in future studies.